6ANI
Coltuximab Fab in complex with anti-Kappa VHH domain
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | CLSI BEAMLINE 08ID-1 |
Synchrotron site | CLSI |
Beamline | 08ID-1 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2015-04-28 |
Detector | RAYONIX MX-300 |
Wavelength(s) | 0.97949 |
Spacegroup name | C 1 2 1 |
Unit cell lengths | 182.390, 48.301, 128.547 |
Unit cell angles | 90.00, 104.07, 90.00 |
Refinement procedure
Resolution | 46.600 - 2.400 |
R-factor | 0.247 |
Rwork | 0.245 |
R-free | 0.28600 |
RMSD bond length | 0.003 |
RMSD bond angle | 0.618 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | PHASER |
Refinement software | PHENIX ((1.12_2829: ???)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 46.596 | 2.440 |
High resolution limit [Å] | 2.400 | 2.400 |
Rmerge | 0.142 | 0.683 |
Rpim | 0.074 | 0.372 |
Number of reflections | 43226 | |
<I/σ(I)> | 9.18 | |
Completeness [%] | 99.4 | |
Redundancy | 4.33 | |
CC(1/2) | 0.993 | 0.583 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 293 | 0.2 M magnesium chloride, 0.1 M HEPES, pH 7.0 and 14 % polyethyleneglycol (PEG) 3350 (w/v) |